Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,501 INR | -1.29% | -1.42% | +19.19% |
Sales 2024 * | 485B 5.83B | Sales 2025 * | 538B 6.46B | Capitalization | 3,647B 43.78B |
---|---|---|---|---|---|
Net income 2024 * | 93.04B 1.12B | Net income 2025 * | 113B 1.35B | EV / Sales 2024 * | 7.31 x |
Net cash position 2024 * | 97.98B 1.18B | Net cash position 2025 * | 161B 1.94B | EV / Sales 2025 * | 6.47 x |
P/E ratio 2024 * |
38.9
x | P/E ratio 2025 * |
32.3
x | Employees | 41,000 |
Yield 2024 * |
0.81% | Yield 2025 * |
0.94% | Free-Float | 45.31% |
Latest transcript on Sun Pharmaceutical Industries Ltd.
1 day | -0.80% | ||
1 week | -0.97% | ||
Current month | -6.95% | ||
1 month | -5.64% | ||
3 months | +7.65% | ||
6 months | +36.63% | ||
Current year | +19.73% |
Managers | Title | Age | Since |
---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
Founder | 68 | 81-12-31 | |
Director of Finance/CFO | - | 17-06-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 68 | 81-12-31 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21-05-20 |
Rolf K. Hoffmann
BRD | Director/Board Member | 63 | 23-06-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.72% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1,501 | -1.29% | 1 437 579 |
24-04-25 | 1,520 | +2.32% | 3,846,327 |
24-04-24 | 1,486 | +0.07% | 4,652,803 |
24-04-23 | 1,485 | -3.60% | 9,160,422 |
24-04-22 | 1,540 | +1.14% | 1,680,307 |
Delayed Quote NSE India S.E., April 26, 2024 at 02:48 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.73% | 43.78B | |
+20.44% | 21.89B | |
+13.49% | 14.45B | |
+13.55% | 13.63B | |
+38.28% | 11.49B | |
-8.59% | 6.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.35% | 5.06B | |
-5.36% | 4.66B |
- Stock Market
- Equities
- SUNPHARMA Stock